Abzu develops AI technology to bridge the gap between data and discoveries, focusing on applications in disease understanding and drug design.

Abzu

Abzu is the best in class in silico disease understanding and drug design company. Since its founding in 2018, Abzu’s proprietary explainable AI, the QLattice®, has been the cornerstone to their cutting-edge approach. Abzu is a preferred partner for pharma, biotech, and research institutions, transforming data into insights and accelerating R&D.

Abzu has offices in Copenhagen and Barcelona, and has raised €13.3M in total funding to date. Abzu has been mentioned in Gartner® research, from Market Guides for AI Trust, Risk, and Security Management to Cool Vendor™, and is the winner of several awards, including the 2023 “Best HealthTech” Nordics Award at the Nordic Startup Awards.

European Innovation Council

Innovation Fund Denmark

Vaekstfonden

Inventure

Seed Capital

We find ourselves in great company as a finalist for Best Healthtech in the Global Startup Awards! Remember to cast your vote for us in the Best Healthtech category here:
https://lnkd.in/dv98Srhn

Congratulations to all the finalists, and best of luck!

We’re OVER THE MOON-excited to reveal that we’ve shattered our previous record for public voting in edition X, with an incredible 121% increase in votes compared to the prior edition! 🎉 

This surge in engagement underscores the significant impact that public voting has on our competition and highlights the passion of our global startup community.

But the excitement doesn’t stop here! Public voting is STILL OPEN, and you still have the chance to rally your supporters and make your voice heard. 📢

To all the incredible startups and ecosystem heroes out there—now’s the time to energize your network and encourage them to cast their votes.

Let’s keep this momentum going and make this year’s edition the most impactful yet!

Thank you for your continued enthusiasm and support. Together, we’re truly shaping the future of entrepreneurship! 🌟

🗳️ Cast your votes here:
https://lnkd.in/dfs6pukQ

#GlobalStartupAwards #startups #innovation #future #business

Abzu's presentation: "From prediction to precision: Getting closer to in silico designs that work in humans" at RNA Leaders 🤩 

 👕 You can't miss us in our Abzu shirts! 👕

🪁 Feyn 3.4.0 has just been released 🪁. This update brings automatic detection of model output based on your data and style improvements to a few plots to make them easier to read 📊.

We've also introduced a helper to flip colormaps to make it easier to match your predicted outcomes in classification 🚦.

In addition, we have a number of bug fixes 🐛 and we've calibrated the eagerness of our data type detection to improve performance for some edge cases 🧮.

Let us at Abzu know what you think, and take a look at our documentation for the full rundown 💜
https://docs.abzu.ai/

#AI #explainableai #symbolicai #research #science #python #datascience #QLattice

🟢#WeAreCataloniaBioHT is launching a new space for analysis to give a voice to our main asset: our members. A new opinion forum to make us stop and reflect on the effects that changes in the environment may have on companies in the #health sector.

Our first topic: Navigating the EU #AI Act in Life Sciences. On March 2024, lawmakers in the European Parliament approved by majority vote a new law to regulate AI systems, the first-ever legal framework on #ArtificialIntelligence

🖋 Read what Casper Wilstrup, CEO of Abzu, has to say on the matter, on our very first #CBHTribune 👉 https://tuit.cat/n6V9D

If you missed Casper Wilstrup's presentation "Illuminating the black box: The imperative of explainable AI in Pharma" at the Relevent AI & Big Data - Life Science conference -- no stress! Let's schedule a ☕ 🤝 

Get in touch 👉 https://lnkd.in/dsKMNj2x

AI:ABZU

Abzu

name

homepage url

country

linkedin url

employee count

sector

industry

Description

investor of

competitor of

Metrics